Protein Changes in Children Having Heart Surgery
Part of Heart & circulation clinical trials.
This study looks at a specific protein change in blood and heart tissue of children having heart surgery with a heart-lung machine. The goal is to understand how this protein might affect recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 0 and 17 years old.
- Your child must be having heart surgery that uses a heart-lung machine.
- Your child must not have an infection, fever, or a weak immune system.
- Your child must not have a metabolic, blood, or genetic disorder.
- You and your child must agree to join the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how much donated blood (blood products) is needed for younger adults during heart surgery that uses a heart-lung machine. It may help doctors choose safer, more appropriate blood-saving plans for people like you.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This study looks at whether a simple blood test can predict a serious heart problem called low cardiac output syndrome after a child has heart surgery. Doctors hope this will help them spot and treat this issue earlier, which could lead to better recovery for your child.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
This study looks at proteins in the blood that may help doctors understand how children are recovering after heart surgery. It enrolls children under age 5 having certain types of heart repairs at Boston Children's Hospital.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.